TPO content has been shown to be significantly lower in thyroid malignancies as compared to benign conditions and normal tissue [2]; also, a reduction in TPO activity and TPO mRNA of 55–70 % is observed in differentiated thyroid carcinoma (DTC) [1, 3]. This evidence concerns the gene TPO and differentiated thyroid carcinoma.